Cargando…
Age is associated with time in therapeutic range for warfarin therapy in patients with atrial fibrillation
BACKGROUND: Warfarin is the most prescribed oral anticoagulant used for preventing stroke in patients with atrial fibrillation. Time in the therapeutic range (TTR) has been accepted as the best method to evaluate the quality of warfarin therapy. The main aim of the present study was to evaluate the...
Autores principales: | Marcatto, Leiliane Rodrigues, Sacilotto, Luciana, da Costa Darrieux, Francisco Carlos, Hachul, Denise Tessariol, Scanavacca, Maurício Ibrahim, Krieger, Jose Eduardo, Pereira, Alexandre Costa, Lima Santos, Paulo Caleb Junior |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342334/ https://www.ncbi.nlm.nih.gov/pubmed/27486984 http://dx.doi.org/10.18632/oncotarget.10944 |
Ejemplares similares
-
Pharmaceutical Care Increases Time in Therapeutic Range of Patients With Poor Quality of Anticoagulation With Warfarin
por: Marcatto, Leiliane Rodrigues, et al.
Publicado: (2018) -
Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range – study protocol for a randomized controlled trial
por: Marcatto, Leiliane Rodrigues, et al.
Publicado: (2016) -
Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation Therapy
por: Marcatto, Leiliane Rodrigues, et al.
Publicado: (2020) -
Controle do Intervalo QT para Prevenção de Torsades de Pointes Durante uso de Hidroxicloroquina e/ou Azitromicina em Pacientes com COVID 19
por: Wu, Tan Chen, et al.
Publicado: (2020) -
Effects of anthracycline, cyclophosphamide and taxane chemotherapy on QTc measurements in patients with breast cancer
por: Veronese, Pedro, et al.
Publicado: (2018)